JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li-Smerin, Y.
Right arrow Articles by Johnson, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li-Smerin, Y.
Right arrow Articles by Johnson, J. W.

Vol. 292, Issue 3, 1104-1110, March 2000

Inhibition by Intracellular Mg2+ of Recombinant N-Methyl-D-aspartate Receptors Expressed in Chinese Hamster Ovary Cells1

Yingying Li-Smerin2 , Elias Aizenman and Jon W. Johnson

Department of Neuroscience, University of Pittsburgh (Y.L.-S., J.W.J.) and Department of Neurobiology, University of Pittsburgh School of Medicine (E.A.), Pittsburgh, Pennsylvania

Intracellular Mg2+ (Mgi2+) inhibits the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors in cultured cortical neurons. To examine the effects of Mgi2+ on recombinant NMDA receptors composed of subunit combinations found in cortical neurons, we expressed heteromeric receptors composed of NR1/NR2A and of NR1/NR2B subunits in Chinese hamster ovary (CHO) cells. We recorded whole-cell currents from the recombinant receptors in the absence and presence of Mgi2+. The voltage dependence of control (0 Mgi2+) NMDA-activated currents obtained from CHO cells transfected with NR1/NR2A and with NR1/NR2B receptors showed outward rectification, a property that has been observed previously in native cortical NMDA receptors. The magnitude and voltage dependence of inhibition by Mgi2+ of NMDA-activated currents were similar in CHO cells transfected with NR1/NR2A receptors, CHO cells transfected with NR1/NR2B receptors, and in cultured neurons expressing native NMDA receptors. These observations suggest that Mgi2+ has uniform effects on the native NMDA receptors expressed in cortical neurons. Furthermore, inhibition by Mgi2+ must not depend on intracellular factors or post-translational receptor modifications that are specific to neurons. Finally, the results indicate that the previously observed differences between whole-cell and outside-out patch measurements of Mgi2+ inhibition could not result from poor control of voltage or Mgi2+ concentration in the dendrites of neurons. The most likely alternative explanation is that patch excision causes an alteration in NMDA receptors that results in more effective inhibition by Mgi2+.


1 This work was supported by National Institutes of Health Grants MH45817 and MH00944 (to J.W.J.) and NS29365 (to E.A.), and by National Institute of Mental Health Training Grant T32 MH18273 (to Y.L.-S.).

2 Current address: Molecular Physiology and Biophysics Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.


0022-3565/00/2923-1104$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurosci.Home page
T. A. Blanpied, R. J. Clarke, and J. W. Johnson
Amantadine Inhibits NMDA Receptors by Accelerating Channel Closure during Channel Block
J. Neurosci., March 30, 2005; 25(13): 3312 - 3322.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.